{
    "organizations": [],
    "uuid": "826b28199bb43a3674165369c93f37df6dd0c14b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-elsalys-biotech-announces-registra/brief-elsalys-biotech-announces-registration-of-its-document-de-base-for-paris-ipo-idUSFWN1RX0B8",
    "ord_in_thread": 0,
    "title": "BRIEF-Elsalys Biotech Announces Registration Of Its Document De Base For Paris IPO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Elsalys Biotech:\n* ELSALYS BIOTECH ANNOUNCES THE REGISTRATION OF ITS DOCUMENT DE BASE IN THE CONTEXT OF ITS PROPOSED INITIAL PUBLIC OFFERING ON THE PARIS EURONEXT GROWTH(Â®) MARKET\n ",
    "published": "2018-04-20T14:33:00.000+03:00",
    "crawled": "2018-04-21T17:51:42.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "elsalys",
        "biotech",
        "elsalys",
        "biotech",
        "announces",
        "registration",
        "document",
        "de",
        "base",
        "context",
        "proposed",
        "initial",
        "public",
        "offering",
        "paris",
        "euronext",
        "growth",
        "market"
    ]
}